Journal of Ovarian Research

(The median citation count of Journal of Ovarian Research is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-10-01 to 2023-10-01.)
Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis115
Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review95
A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective65
Ovarian cancer stem cells and targeted therapy62
BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases54
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review53
miR-552 promotes ovarian cancer progression by regulating PTEN pathway48
YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells47
Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells46
Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age45
Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer45
Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review40
Withaferin A: a potential therapeutic agent against COVID-19 infection38
circRNA-UBAP2 promotes the proliferation and inhibits apoptosis of ovarian cancer though miR-382-5p/PRPF8 axis34
Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis34
Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells32
Long non-coding RNAs in ovarian granulosa cells31
Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer31
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized31
Therapeutic role of curcumin and its novel formulations in gynecological cancers30
Ovary does harbor stem cells - size of the cells matter!28
Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer28
Circular RNA hsa_circ_0078607 suppresses ovarian cancer progression by regulating miR-518a-5p/Fas signaling pathway28
MiR-200b is upregulated in plasma-derived exosomes and functions as an oncogene by promoting macrophage M2 polarization in ovarian cancer28
Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells26
Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols26
Adipocytes: active facilitators in epithelial ovarian cancer progression?26
LINC01094/miR-577 axis regulates the progression of ovarian cancer26
The differential distribution of bacteria between cancerous and noncancerous ovarian tissues in situ25
Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer25
Functional activities of beta-glucans in the prevention or treatment of cervical cancer25
Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis24
Recent trends in stem cell therapy for premature ovarian insufficiency and its therapeutic potential: a review24
Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses24
Anti-tumor activities of probiotics in cervical cancer24
Whole-exome sequencing in patients with premature ovarian insufficiency: early detection and early intervention24
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells23
The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis23
The role of oxidative stress in ovarian aging: a review23
Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review23
Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer23
A novel EIF4ENIF1 mutation associated with a diminished ovarian reserve and premature ovarian insufficiency identified by whole-exome sequencing21
Association between morphologic grading and implantation rate of Euploid blastocyst21
MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ21
An overview of FSH-FSHR biology and explaining the existing conundrums20
The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis20
Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis20
The Jun N-terminal kinases signaling pathway plays a “seesaw” role in ovarian carcinoma: a molecular aspect20
Baicalin ameliorates polycystic ovary syndrome through AMP-activated protein kinase19
Predicting complete cytoreduction for advanced ovarian cancer patients using nearest-neighbor models19
Tumor-suppressor miRNA-27b-5p regulates the growth and metastatic behaviors of ovarian carcinoma cells by targeting CXCL119
Cul4B promotes the progression of ovarian cancer by upregulating the expression of CDK2 and CyclinD119
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A19
Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients18
Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging18
Decreased ovarian function and autophagy gene methylation in aging rats18
Identification of an autophagy-related gene signature for survival prediction in patients with cervical cancer18
Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis17
Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study17
Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis17
Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer17
Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment17
Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling16
Ovarian endometrioma – a possible finding in adolescent girls and young women: a mini-review16
RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis16
Comparison of methods for quantifying primordial follicles in the mouse ovary16
Melatonin enhances SIRT1 to ameliorate mitochondrial membrane damage by activating PDK1/Akt in granulosa cells of PCOS16
Prediction of the treatment response in ovarian cancer: a ctDNA approach16
The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal‐weight population16
Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis15
Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysis15
Transcriptomics of cumulus cells – a window into oocyte maturation in humans15
RETRACTED ARTICLE: Long non-coding RNA PTPRG-AS1 promotes cell tumorigenicity in epithelial ovarian cancer by decoying microRNA-545-3p and consequently enhancing HDAC4 expression15
Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses15
Olaparib in the therapy of advanced ovarian cancer: first real world experiences in safety and efficacy from China15
Influence of marital status on overall survival in patients with ovarian serous carcinoma: finding from the surveillance epidemiology and end results (SEER) database15
miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcino15
Estrogen enhances the proliferation and migration of ovarian cancer cells by activating transient receptor potential channel C314
Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer14
Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis14
Targeting purine metabolism in ovarian cancer14
S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin14
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?14
Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer14
The abnormal level of HSP70 is related to Treg/Th17 imbalance in PCOS patients13
FMRpolyG accumulates in FMR1 premutation granulosa cells13
A combination of spearmint and flaxseed extract improved endocrine and histomorphology of ovary in experimental PCOS13
Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancer13
Rare homozygous mutation in TUBB8 associated with oocyte maturation defect-2 in a consanguineous mating family13
RETRACTED ARTICLE: LncRNA miR503HG interacts with miR-31-5p through multiple ways to regulate cancer cell invasion and migration in ovarian cancer13
H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis13
Long non-coding RNA THOR promotes ovarian Cancer cells progression via IL-6/STAT3 pathway13
Telomere length in granulosa cells and leukocytes: a potential marker of female fertility? A systematic review of the literature13
MicroRNA-145-5p regulates the proliferation of epithelial ovarian cancer cells via targeting SMAD413
MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer12
Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy12
RETRACTED ARTICLE: LncRNA CTBP1-AS2 sponges miR-216a to upregulate PTEN and suppress endometrial cancer cell invasion and migration12
UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway12
Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression12
LncRNA DLEU1 is overexpressed in premature ovarian failure and sponges miR-146b-5p to increase granulosa cell apoptosis12
Characteristics and treatment results of recurrence in adult-type granulosa cell tumor of ovary12
Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature12
CACNA1C is a prognostic predictor for patients with ovarian cancer12
Health related quality of life and psychological parameters in different polycystic ovary syndrome phenotypes: a comparative cross-sectional study12
Effect of Endometrioma cystectomy on cytokines of follicular fluid and IVF outcomes12
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer12
Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome12
MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer12
Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer11
The role of MMP-14 in ovarian cancer: a systematic review11
Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway11
LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p11
Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice11
Systematic analysis of ovarian cancer platinum-resistance mechanisms via text mining11
Aged mice ovaries harbor stem cells and germ cell nests but fail to form follicles11
Randomized double blind clinical trial evaluating the Ellagic acid effects on insulin resistance, oxidative stress and sex hormones levels in women with polycystic ovarian syndrome11
LncRNA HOTAIRM1, miR-433-5p and PIK3CD function as a ceRNA network to exacerbate the development of PCOS11
LncRNA TONSL-AS1 regulates miR-490-3p/CDK1 to affect ovarian epithelial carcinoma cell proliferation11
Long non-coding RNA AOC4P suppresses epithelial ovarian cancer metastasis by regulating epithelial-mesenchymal transition11
Comparison of the predictive performance of risk of malignancy indexes 1–4, HE4 and risk of malignancy algorithm in the triage of adnexal masses11
Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?11
Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression11
Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer11
miR-145 inhibits mitochondrial function of ovarian cancer by targeting ARL5B11
Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study11
Adverse reproductive health outcomes in a cohort of young women with breast cancer exposed to systemic treatments11
Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism11
Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma11
Lipid droplets in granulosa cells are correlated with reduced pregnancy rates11
Ameliorative effect of recombinant human lactoferrin on the premature ovarian failure in rats after cyclophosphamide treatments11
p38β - MAPK11 and its role in female cancers10
Identification of WTAP-related genes by weighted gene co-expression network analysis in ovarian cancer10
Construction autophagy-related prognostic risk signature to facilitate survival prediction, individual treatment and biomarker excavation of epithelial ovarian cancer patients10
MiR-23a induced the activation of CDC42/PAK1 pathway and cell cycle arrest in human cov434 cells by targeting FGD410
LncRNA CTBP1-AS2 regulates miR-216a/ PTEN to suppress ovarian cancer cell proliferation10
Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications10
Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS)10
Association between atypical endometriosis and ovarian malignancies in the real world10
Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing10
TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells10
Endogenous, tissue-resident stem/progenitor cells in gonads and bone marrow express FSHR and respond to FSH via FSHR-310
The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats10
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer10
Age-related decline in the expression of GDF9 and BMP15 genes in follicle fluid and granulosa cells derived from poor ovarian responders10
Mutation analysis of the TUBB8 gene in primary infertile women with oocyte maturation arrest10
The boosting effects of melatonin on the expression of related genes to oocyte maturation and antioxidant pathways: a polycystic ovary syndrome- mouse model10
A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer10
A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer10
Two-dimensional and three-dimensional T2 weighted imaging-based radiomic signatures for the preoperative discrimination of ovarian borderline tumors and malignant tumors10
Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA9
HVEM/HIF-1α promoted proliferation and inhibited apoptosis of ovarian cancer cells under hypoxic microenvironment conditions9
Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis9
Berberine inhibited metastasis through miR-145/MMP16 axis in vitro9
Impact of the COVID-19 epidemic at a high-volume facility in gynecological oncology in Tokyo, Japan: a single-center experience9
Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture9
Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer9
Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer9
Long-term multidisciplinary integrative therapy management resulted in favorable outcomes for ovarian cancer during pregnancy: a case report and literature review9
Long non-coding RNA AFAP1-AS1 facilitates ovarian cancer progression by regulating the miR-107/PDK4 axis9
Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a ret9
Pure dysgerminoma of the ovary: CT and MRI features with pathological correlation in 13 tumors9
Development and validation of circulating CA125 prediction models in postmenopausal women9
Neuropeptide Y regulates proliferation and apoptosis in granulosa cells in a follicular stage-dependent manner9
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer8
BDNF and TrKB expression levels in patients with endometriosis and their associations with dysmenorrhoea8
Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma8
LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis8
Characterization of a novel mutation V136L in bone morphogenetic protein 15 identified in a woman affected by POI8
Trophectoderm biopsy of blastocysts for a preimplantation genetic test does not affect serum β-hCG levels in early pregnancy: a study using propensity score matching8
Integrative analysis of transcription factors and microRNAs in ovarian cancer cell spheroids8
Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer8
Sentinel lymph node identification in early stage ovarian cancer: is it still possible after prior tumor resection?8
Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study8
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report8
Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA1258
Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo8
Maintenance therapy for newly diagnosed epithelial ovarian cancer– a review8
Effect of blastocyst morphology and developmental speed on transfer strategy for grade “C” blastocyst in vitrified‐warmed cycles8
Role of different non-coding RNAs as ovarian cancer biomarkers8
Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors8
Successful live birth in a Chinese woman with P450 oxidoreductase deficiency through frozen-thawed embryo transfer: a case report with review of the literature8
Persistently elevated alpha-fetoprotein associated with chronic hepatitis B during chemotherapy for malignant ovarian germ cell tumors: a case series and a review of the literature8
Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles8
Depletion of GPSM1 enhances ovarian granulosa cell apoptosis via cAMP-PKA-CREB pathway in vitro8
Performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) in diagnosis of ovarian cancer: a systematic review and meta-analysis8
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer7
FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization7
Down-regulation of ZNF252P-AS1 alleviates ovarian cancer progression by binding miR-324-3p to downregulate LY6K7
Assisted hatching of vitrified-warmed blastocysts prior to embryo transfer does not improve pregnancy outcomes7
Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China7
A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer7
Effects of the sperm DNA fragmentation index on the clinical and neonatal outcomes of intracytoplasmic sperm injection cycles7
Comparison of dietary micronutrient intake in PCOS patients with and without metabolic syndrome7
Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors7
Minimal residual disease detection by multicolor flow cytometry in cryopreserved ovarian tissue from leukemia patients7
WISP2 promotes cell proliferation via targeting ERK and YAP in ovarian cancer cells7
Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway7
Fertility care amidst the COVID19 pandemic: the American experience7
Lipidomics analysis of human follicular fluid form normal-weight patients with polycystic ovary syndrome: a pilot study7
Short (seven days) versus standard (fourteen days) oestrogen administration in a programmed frozen embryo transfer cycle: a retrospective cohort study7
Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA67
Induced premature ovarian insufficiency by using D galactose and its effects on reproductive profiles in small laboratory animals: a systematic review7
Platelet count as a biomarker for monitoring treatment response and disease recurrence in recurrent epithelial ovarian cancer7
Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation7
Ovarian endometrioma infiltrating neutrophils orchestrate immunosuppressive microenvironment7
Comparison of the survival outcomes of laparoscopy versus laparotomy in treatment of early-stage ovarian cancer: a systematic review and meta-analysis7
Small RNA sequencing reveals distinct nuclear microRNAs in pig granulosa cells during ovarian follicle growth7
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer7
Ovarian sex cord stromal tumours: analysis of the clinical and sonographic characteristics of different histopathologic subtypes7
Predictive value of the number of frozen blastocysts in live birth rates of the transferred fresh embryos6
A risk model of gene signatures for predicting platinum response and survival in ovarian cancer6
The survival effect of ovary preservation in early stage endometrial cancer: a single institution retrospective analysis6
A poor prognostic metastatic nongestational choriocarcinoma of the ovary: a case report and the literature review6
Can polymorphisms of AMH/AMHR2 affect ovarian stimulation outcomes? A systematic review and meta-analysis6
microRNA-1271-5p/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway6
MiR-425-5p accelerated the proliferation, migration, and invasion of ovarian cancer cells via targeting AFF46
ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis6
Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats6
LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis6
Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network6
Ovarian reserve in nigerian women with sickle cell anaemia: a cross- sectional study6
The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p6
Identification of novel candidate biomarkers and immune infiltration in polycystic ovary syndrome6
The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis6
The challenge of ovarian tissue culture: 2D versus 3D culture6
RETRACTED ARTICLE: The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer6
Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer6
The presence of living endometrial cells in ovarian endometriotic cyst fluid may contribute to the recurrence of endometriosis after surgical excision of endometriomas6
Poorer prognosis of ovarian squamous cell carcinoma than serous carcinoma: a propensity score matching analysis based on the SEER database6
LncRNA TMPO-AS1 suppresses the maturation of miR-335-5p to participate in polycystic ovary syndrome6
Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling6
The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve6
COVID-19 in Africa: an ovarian victory?6
Salpingectomy may decrease antral follicle count but not live birth rate for IVF-ET patients aged 35–39 years: a retrospective study6
Identification and clinical significance of somatic oncogenic mutations in epithelial ovarian cancer6
LncRNA AB209371 up-regulated Survivin gene by down-regulating miR-203 in ovarian carcinoma6
Ovarian seromucinous tumors: clinicopathological features of 10 cases with a detailed review of the literature6
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer6
Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR6
Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia6
LncRNA GAS5 is upregulated in polycystic ovary syndrome and regulates cell apoptosis and the expression of IL-66
Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p/BCL2 axis6
RETRACTED ARTICLE: MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells6
High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer6
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers6
Clinical analysis and artificial intelligence survival prediction of serous ovarian cancer based on preoperative circulating leukocytes6
Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics6
Activated CAMKKβ-AMPK signaling promotes autophagy in a spheroid model of ovarian tumour metastasis6
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy5
Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer5
Quercetin alleviates cyclophosphamide-induced premature ovarian insufficiency in mice by reducing mitochondrial oxidative stress and pyroptosis in granulosa cells5
Diagnostic utility of a conventional MRI-based analysis and texture analysis for discriminating between ovarian thecoma-fibroma groups and ovarian granulosa cell tumors5
Polycystic ovary rat model exposure to 150 kHz intermediate frequency: hypothalamic-pituitary-ovarian axis at the receptor, cellular, tissue, and hormone levels5
Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma5
Female germline stem cells: aging and anti-aging5
Genetic determination of the ovarian reserve: a literature review5
Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells5
Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors5
Low-dose human menopausal gonadotrophin versus natural cycles in intrauterine insemination for subfertile couples with regular menstruation5
Metabolic differences in women with premature ovarian insufficiency: a systematic review and meta-analysis5
Ovarian microcystic stromal tumor with omental metastasis: the first case report and literature review5
Galectin-1 as a predictive biomarker in ovarian cancer5
The effect of prophylactic bilateral salpingectomy on ovarian reserve in patients who underwent laparoscopic hysterectomy5
Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: a systematic review5
Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients5
Integrative analysis of the common genetic characteristics in ovarian cancer stem cells sorted by multiple approaches5
Comparison of the umbilical cord Blood’s anti-Mullerian hormone level in the newborns of mothers with polycystic ovary syndrome (PCOS) and healthy mothers5
Predictive factors of endometriosis progression into ovarian cancer5
Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling5
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer5
Expression of long noncoding RNAs in the ovarian granulosa cells of women with diminished ovarian reserve using high-throughput sequencing5
Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present5
Construction and validation of a transcription factors-based prognostic signature for ovarian cancer5
Elucidating Decorin’s role in the preovulatory follicle5
Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection5
Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer5
Plumbagin rescues the granulosa cell’s pyroptosis by reducing WTAP-mediated N6-methylation in polycystic ovary syndrome5
The differential expression of miRNAs between ovarian endometrioma and endometriosis-associated ovarian cancer5
Is polycystic ovary syndrome appropriately diagnosed by obstetricians and gynaecologists across China: a nationwide survey5
Low expression of NCALD is associated with chemotherapy resistance and poor prognosis in epithelial ovarian cancer5
Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma5
Troxerutin protects against DHT-induced polycystic ovary syndrome in rats5
Effects and mechanisms of mUCMSCs on ovarian structure and function in naturally ageing C57 mice5
Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status5
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals5
The enhancer RNA ADCY10P1 is associated with the progression of ovarian cancer5
miR-600 promotes ovarian cancer cells stemness, proliferation and metastasis via targeting KLF95
Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis5
A flexible short protocol in women with poor ovarian response over 40 years old5
Lnc-GULP1–2:1 affects granulosa cell proliferation by regulating COL3A1 expression and localization5
The impact of STAT3 and phospho-STAT3 expression on the prognosis and clinicopathology of ovarian cancer: a systematic review and meta-analysis5
Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer4
Tumor burden is a potential marker of PARP inhibitor effects in ovarian cancer: a head-to-head observational series4
Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer4
Ovarian metastasis from nongynecologic primary sites: a retrospective analysis of 177 cases and 13-year experience4
Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation4
Effects of exogenous adiponectin supplementation in early pregnant PCOS mice on the metabolic syndrome of adult female offspring4
Overexpression of NCAPG in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via p38 MAPK signaling pathway4
Comparison of oocyte vitrification using a semi-automated or a manual closed system in human siblings: survival and transcriptomic analyses4
miR-4324 inhibits ovarian cancer progression by targeting FEN14
Long non-coding RNA FAM83H-AS1 acts as a potential oncogenic driver in human ovarian cancer4
Sonographic features differentiating early-stage ovarian clear cell carcinoma from endometrioma with atypical features4
miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer4
Chronic exposure to perfluorohexane sulfonate leads to a reproduction deficit by suppressing hypothalamic kisspeptin expression in mice4
NOTCH2 variant D1853H is mutated in two non-syndromic premature ovarian insufficiency patients from a Chinese pedigree4
Degenerated oocyte in the cohort adversely affects IVF outcome4
Effect of animal-sourced bioactive peptides on the in vitro development of mouse preantral follicles4
Challenges and opportunities for ovarian cancer management in the epidemic of Covid-19: lessons learned from Wuhan, China4
A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview4
Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics4
The efficacy and safety of niraparib for ovarian cancer: a single-center observational study from China4
High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer4
Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer4
Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome4
Neoantigens and the tumor microenvironment play important roles in the prognosis of high-grade serous ovarian cancer4
Ovarian inguinal hernia – a possibility in MURCS syndrome4
Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients4
Evaluation of mitochondria in mouse oocytes following cisplatin exposure4
LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer4
The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis4
Development of a multi-gene-based immune prognostic signature in ovarian Cancer4
STAT4 targets KISS1 to promote the apoptosis of ovarian granulosa cells4
Plasma metabolomic characterization of premature ovarian insufficiency4
Decidualized ovarian endometrioma mimicking malignancy in pregnancy: a case report and literature review4
Lifetime ovulatory years and ovarian cancer gene expression profiles4
MR-based radiomics-clinical nomogram in epithelial ovarian tumor prognosis prediction: tumor body texture analysis across various acquisition protocols4
Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters4
The impact of Pegylated liposomal doxorubicin in recurrent ovarian cancer: an updated meta-analysis of randomized clinical trials4
A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis4
A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapy4
Prostatic-specific antigen (PSA) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis4
CircSETDB1 knockdown inhibits the malignant progression of serous ovarian cancer through miR-129-3p-dependent regulation of MAP3K34
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer4
Laser-assisted hatching in lower grade cleavage stage embryos improves blastocyst formation: results from a retrospective study4
High expression level of miR-1260 family in the peripheral blood of patients with ovarian carcinoma4
Changes in serum markers of patients with PCOS during consecutive clomiphene stimulation cycles: a retrospective study4
Identification of key gene signatures for the overall survival of ovarian cancer4
Bioinformatic analysis reveals MIR502 as a potential tumour suppressor in ovarian cancer4
CT-based machine learning radiomics predicts CCR5 expression level and survival in ovarian cancer4
Bioinformatics analysis of gene expression profile of serous ovarian carcinomas to screen key genes and pathways3
Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers3
Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq3
A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy3
Effects of activating GABAB1 receptor on proliferation, migration, invasion and epithelial-mesenchymal transition of ovarian cancer cells3
Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?3
Investigation of the mechanisms and experimental verification of Cuscuta-Salvia in the treatment of polycystic ovary syndrome (PCOS) via network pharmacology3
Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression3
Chemoprotective effects of plasma derived from mice of different ages and genders on ovarian failure after cyclophosphamide treatment3
Low risk of OHSS with follitropin delta use in women with different polycystic ovary syndrome phenotypes: a retrospective case series3
High visceral fat-to-muscle ratio is an independent factor that predicts worse overall survival in patients with primary epithelial ovarian, fallopian tube, and peritoneal cancer3
Ovarian fibrosarcoma: A single-institution experience and a review of the literature3
A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer3
Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer3
RETRACTED ARTICLE: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo3
Bevacizumab confers significant improvements in survival for ovarian cancer patients with low miR-25 expression and high miR-142 expression3
Retraction Note: LncRNA CTBP1-AS2 sponges miR-216a to upregulate PTEN and suppress endometrial cancer cell invasion and migration3
Association between the food security status and dietary patterns with polycystic ovary syndrome (PCOS) in overweight and obese Iranian women: a case-control study3
Extended doxycycline treatment versus salpingectomy in the management of patients with hydrosalpinx undergoing IVF-ET3
Baicalin improves the functions of granulosa cells and the ovary in aged mice through the mTOR signaling pathway3
Does Anti-Müllerian hormone vary during a menstrual cycle? A systematic review and meta-analysis3
Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients3
Transferrin and antioxidants partly prevented mouse oocyte oxidative damage induced by exposure of cumulus-oocyte complexes to endometrioma fluid3
Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study3
Differential expression of long non-coding RNA Regulator of reprogramming and its molecular mechanisms in polycystic ovary syndrome3
Pannexin 1 inhibition delays maturation and improves development of Bos taurus oocytes3
CPEB1 deletion is not a common explanation for premature ovarian insufficiency in a Chinese cohort3
Ginseng alleviates folliculogenesis disorders via induction of cell proliferation and downregulation of apoptotic markers in nicotine-treated mice3
Characteristics and outcomes analysis of ovarian Sertoli–Leydig cell tumors (SLCTs): analysis of 15 patients3
Mechanisms of ovarian aging in women: a review3
Simultaneous expression of steroid sulfatase and androgen receptor reduced overall survival of patients with epithelial ovarian tumors3
Bioinformatics analysis of prognostic value and prospective pathway signal of miR-30a in ovarian cancer3
Primitive ovarian carcinosarcoma: a clinical and radiological analysis of five cases3
Ovarian neoplasia in adolescence: a retrospective chart review of girls with neoplastic ovarian tumors in Saudi Arabia3
Anti-proliferative activities of Byrsocarpus coccineus Schum. and Thonn. (Connaraceae) using ovarian cancer cell lines3
Patient with ovarian insufficiency: baby born after anticancer therapy and re-transplantation of cryopreserved ovarian tissue3
Ovarian tissue cryopreservation in a patient with breast cancer during pregnancy: a case report3